Aprea Therapeutics
APRE
#10464
Rank
HK$89.65 M
Marketcap
HK$7.24
Share price
1.05%
Change (1 day)
-46.27%
Change (1 year)

Market capitalization of Aprea Therapeutics (APRE)

Market cap: HK$89.65 Million

As of May 2026 Aprea Therapeutics has a market cap of HK$89.65 Million. This makes Aprea Therapeutics the world's 10464th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Aprea Therapeutics from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$89.65 M68.09%
2025HK$53.33 M-62.49%
2024HK$0.14 B3.67%
2023HK$0.13 B0.07%
2022HK$0.13 B-71.47%
2021HK$0.48 B-40.55%
2020HK$0.80 B-89.23%
2019HK$7.50 B

End of Day market cap according to different sources

On May 27th, 2026 the market cap of Aprea Therapeutics was reported to be:

HK$88.72 Million
by Nasdaq info icon info icon
HK$88.72 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Magellan Health
MGLN
HK$19.59 B 21,756.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amedisys
AMED
HK$26.02 B 28,922.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
HK$11.07 B 12,256.44%๐Ÿ‡บ๐Ÿ‡ธ USA